GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

GlaxoSmithKline (GB:GSK) has released an update. GlaxoSmithKline’s Blenrep combinations for treating relapsed multiple myeloma have been accepted ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...

PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...

Pharmaceuticals giant GlaxoSmithKline has told thousands of staff to turn off the NHS Covid-19 app while at work. It told them to switch off the Bluetooth contact-tracing feature at its research ...

At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

Nomura cuts GSK Consumer to 'reduce' on high valuations Nomura Financial Advisory and Securities India has downgraded GlaxoSmithKline Consumer Healthcare to "reduce" from "buy" citing high ...

(Alliance News) - GlaxoSmithKline PLC on Thursday said Brian McNamara, chief executive of its Consumer Healthcare unit, has been appointed CEO designate of a new, independent company, which will ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...